Published in Cancer Weekly, March 8th, 1999
In order to optimize HSV-TK/GCV gene therapy, more detailed studies on how the bystander effect works are needed. It is also important that the cells being studied are developed from the same parental cell line.
Laura Z. Rubsam and colleagues from the University of Michigan evaluated GCV cytotoxicity and nucleotide transfer in HSV-TK-expressing and bystander cells generated from a human glioblastoma cell line ("Cytotoxicity and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.